$561.32 Million in Sales Expected for Nu Skin Enterprises, Inc. (NUS) This Quarter
Wall Street brokerages expect Nu Skin Enterprises, Inc. (NYSE:NUS) to post $561.32 million in sales for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Nu Skin Enterprises’ earnings, with the highest sales estimate coming in at $567.09 million and the lowest estimate coming in at $555.54 million. Nu Skin Enterprises reported sales of $499.10 million in the same quarter last year, which indicates a positive year-over-year growth rate of 12.5%. The business is expected to report its next quarterly earnings report on Wednesday, May 2nd.
According to Zacks, analysts expect that Nu Skin Enterprises will report full-year sales of $561.32 million for the current year, with estimates ranging from $2.46 billion to $2.47 billion. For the next fiscal year, analysts anticipate that the business will report sales of $2.53 billion per share. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Nu Skin Enterprises.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, February 15th. The company reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.01. The business had revenue of $666.20 million during the quarter, compared to analyst estimates of $667.39 million. Nu Skin Enterprises had a return on equity of 25.23% and a net margin of 5.68%. Nu Skin Enterprises’s quarterly revenue was up 25.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.79 EPS.
Nu Skin Enterprises (NUS) traded up $1.74 on Wednesday, reaching $72.35. The company’s stock had a trading volume of 465,188 shares, compared to its average volume of 443,279. The company has a market cap of $3,724.68, a price-to-earnings ratio of 30.53, a price-to-earnings-growth ratio of 1.97 and a beta of 1.43. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.74 and a quick ratio of 1.17. Nu Skin Enterprises has a fifty-two week low of $48.72 and a fifty-two week high of $74.45.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 14th. Shareholders of record on Monday, February 26th will be issued a dividend of $0.365 per share. This is an increase from Nu Skin Enterprises’s previous quarterly dividend of $0.36. The ex-dividend date of this dividend is Friday, February 23rd. This represents a $1.46 dividend on an annualized basis and a dividend yield of 2.02%. Nu Skin Enterprises’s dividend payout ratio is 61.60%.
In other Nu Skin Enterprises news, Chairman Steven Lund sold 22,891 shares of the company’s stock in a transaction that occurred on Monday, January 22nd. The stock was sold at an average price of $70.08, for a total transaction of $1,604,201.28. Following the transaction, the chairman now owns 4,769 shares in the company, valued at approximately $334,211.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold a total of 195,978 shares of company stock worth $13,512,733 in the last quarter. Company insiders own 5.20% of the company’s stock.
Several hedge funds have recently bought and sold shares of the business. BlackRock Inc. grew its holdings in shares of Nu Skin Enterprises by 0.8% during the 4th quarter. BlackRock Inc. now owns 6,811,769 shares of the company’s stock worth $464,767,000 after acquiring an additional 55,966 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Nu Skin Enterprises by 5.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,416,305 shares of the company’s stock worth $87,443,000 after acquiring an additional 66,986 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Nu Skin Enterprises by 5.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,125,625 shares of the company’s stock worth $69,204,000 after buying an additional 57,750 shares during the last quarter. Old Mutual Global Investors UK Ltd. grew its stake in shares of Nu Skin Enterprises by 63.1% in the 4th quarter. Old Mutual Global Investors UK Ltd. now owns 821,316 shares of the company’s stock worth $56,038,000 after buying an additional 317,869 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Nu Skin Enterprises by 1.1% in the 4th quarter. Bank of New York Mellon Corp now owns 754,996 shares of the company’s stock worth $51,514,000 after buying an additional 8,462 shares during the last quarter. Hedge funds and other institutional investors own 76.17% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This article was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.dailypolitical.com/2018/03/03/561-32-million-in-sales-expected-for-nu-skin-enterprises-inc-nus-this-quarter.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.